GLSI
Greenwich Lifesciences Inc
15.10$
-1.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.6% | -21.2% | +31.2% | -19.4% | -29.7% | -32.8% | +13.6% | +21.8% | +62.3% | +70.0% | -15.5% | |
| – | -23.6% | -21.2% | +31.2% | -19.4% | -29.8% | -32.8% | +13.6% | +21.8% | +62.3% | +70.0% | -15.5% | |
| – | -23.6% | -21.2% | +31.2% | -19.4% | -29.7% | -32.8% | +13.6% | +21.8% | +62.3% | +70.0% | -15.5% | |
| – | – | – | +31.2% | -19.4% | – | – | +13.6% | +21.8% | – | – | -15.5% | |
| – | -14.3% | -16.8% | -20.1% | -25.2% | -33.7% | -50.8% | – | – | – | – | – | |
| – | -1.0% | +32.3% | +247.3% | -37.7% | +85.2% | -7.8% | +17.2% | -3.8% | +259.1% | -10.1% | +10.0% | |
| – | -1.0% | +32.3% | +247.3% | -37.7% | +85.2% | -7.8% | +17.2% | -3.8% | +259.1% | -10.1% | +10.0% | |
| – | +2,448.6% | -50.9% | +786.3% | -30.5% | +52.0% | -29.8% | +30.1% | +3.1% | +339.6% | -7.5% | +6.6% | |
| – | -24.3% | -23.6% | +14.7% | -15.2% | -49.1% | -48.2% | +9.7% | +51.8% | -83.8% | +1,392.1% | -40.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.1% | +0.4% | +1.8% | +0.1% | +0.1% | +1.5% | +2.0% | +4.8% | +1.9% | +0.4% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.